CPI203
CAS No. 1446144-04-2
CPI203 ( TEN 010;JQ-2;RG-6146 )
Catalog No. M11893 CAS No. 1446144-04-2
CPI 203 (TEN 010, JQ-2, RG-6146) is a primary amide analog of (+)-JQ1and a BET bromodomain inhibitor that shows cytotoxicity against MCL cell lines with GI50 of 0.1-0.3 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 54 | In Stock |
|
5MG | 97 | In Stock |
|
10MG | 155 | In Stock |
|
25MG | 332 | In Stock |
|
50MG | 499 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCPI203
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPI 203 (TEN 010, JQ-2, RG-6146) is a primary amide analog of (+)-JQ1and a BET bromodomain inhibitor that shows cytotoxicity against MCL cell lines with GI50 of 0.1-0.3 uM.
-
DescriptionCPI 203 (TEN 010, JQ-2, RG-6146) is a primary amide analog of (+)-JQ1and a BET bromodomain inhibitor that shows cytotoxicity against MCL cell lines with GI50 of 0.1-0.3 uM; synergizes the antitumor activity of lenalidomide in bortezomib-resistant mantle cell lymphoma; also enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors, overcomes resistance to ABT-199 (Venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma.
-
SynonymsTEN 010;JQ-2;RG-6146
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBRD4
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1446144-04-2
-
Formula Weight399.90
-
Molecular FormulaC19H18ClN5OS
-
Purity>98% (HPLC)
-
SolubilityDMSO: 72 mg/mL (180 mM); Ethanol: 5 mg/mL (12.5 mM); Water: <1 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(N)C[C@H]1C2=NN=C(C)N2C3=C(C(C)=C(C)S3)C(C4=CC=C(Cl)C=C4)=N1
-
Chemical Name(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Moros A, et al. Leukemia. 2014 Oct;28(10):2049-59.
2. Wong C, et al. Cell Death Dis. 2014 Oct 9;5:e1450.
3. Siegel MB, et al. Oncotarget. 2015 Aug 7;6(22):18921-32.
4. Esteve-Arenys A, et al. Oncogene. 2018 Jan 22. doi: 10.1038/s41388-017-0111-1.
2. Wong C, et al. Cell Death Dis. 2014 Oct 9;5:e1450.
3. Siegel MB, et al. Oncotarget. 2015 Aug 7;6(22):18921-32.
4. Esteve-Arenys A, et al. Oncogene. 2018 Jan 22. doi: 10.1038/s41388-017-0111-1.
molnova catalog
related products
-
BRD-IN-26
BRD-IN-26 is a potent bromodomain inhibitor that binds the fifth bromodomain of PB1 with a KD of 124 nM.
-
TP-238
TP-238 (TP238) is a CECR2/BPTF bromodomains chemical probe with IC50 of 30nM against CECR2 and 350nM against BPTF in an alphascreen assay.
-
BRD9-IN-28
BRD9-IN-28 is a highly potent and selective BRD7/9 bromodomain inhibitor with pIC50 of 6.9, Kd of 68 nM for BRD9.